NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

NeuroPace, a medical device company focused on improving the lives of individuals with epilepsy, announced participation in the 22nd Annual Needham Virtual Healthcare Conference. The presentation will take place on April 17, 2023, at 7:15 a.m. PT / 10:15 a.m. ET. A live webcast and an archived recording will be available on the company’s website. NeuroPace is renowned for its RNS System, a brain-responsive platform that delivers real-time treatment to help reduce or eliminate seizures. This innovative technology aims to enhance the standard of care for patients suffering from drug-resistant epilepsy and has potential applications for other brain disorders.

MOUNTAIN VIEW, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will be participating in the upcoming 22^nd Annual Needham Virtual Healthcare Conference.

Management is scheduled to present on Monday, April 17^th, 2023 at 7:15 a.m. Pacific Time / 10:15 a.m. Eastern Time. A live webcast of this event, as well as an archived recording, will be available on the “Investors” section of the company’s website at: https://investors.neuropace.com.

About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.

Investor Contact:
Philip Taylor
Gilmartin Group
investors@neuropace.com

FAQ

What event will NeuroPace participate in, and when is it scheduled?

NeuroPace will participate in the 22nd Annual Needham Virtual Healthcare Conference on April 17, 2023.

What is the significance of the RNS System developed by NeuroPace?

The RNS System is the first and only commercial brain-responsive platform that provides personalized, real-time treatment for patients with drug-resistant epilepsy.

Where can I watch the NeuroPace presentation?

The NeuroPace presentation will be available through a live webcast and an archived recording on their Investors section of the company website.

What time will NeuroPace's presentation take place at the Needham Conference?

NeuroPace's presentation is scheduled for April 17, 2023, at 7:15 a.m. Pacific Time / 10:15 a.m. Eastern Time.

How does NeuroPace aim to help patients with epilepsy?

NeuroPace aims to transform the lives of epilepsy patients by reducing or eliminating seizures through its innovative medical devices.